Resilience, a new biopharmaceutical company backed by $800 million in financing from investors including ARCH Venture Partners and 8VC, has emerged from stealth to...
Oxford University’s COVID-19 vaccine, being developed in partnership with drugmaker AstraZeneca, has shown to be 70.4% effective in preliminary results from its Phase...
State and city leaders are trying to slow the spread of the coronavirus without full lockdowns. But whether curfews will help remains unclear.
Source link...
Researchers from the University of Pennsylvania conducted a study during a measles outbreak last year and concluded that “a relatively high number of individuals...
So far, it has pulled in only $3.6 billion in funding for research, manufacturing and subsidies for poor countries. Three companies have promised to...
This crowding and its adverse consequences are problems in other countries, too. A 2018 National Bureau of Economic Research working paper examined emergency department...
The World Health Organization on Thursday recommended against using the antiviral remdesivir, a drug that had generated intense interest as a treatment for Covid-19.An...